Cryptococcal meningitis

References cited
Article section 14 of 15.  Previous  Next

By Joseph R Berger MD

Alspaugh J, Perfect JR. Cryptococcal meningitis. Curr Treat Opt Infect Dis 2002;4(1):75-80.

Andreula CF, Burdi N, Carella A. CNS cryptococcosis in AIDS: spectrum of MR findings. J Comput Assist Tomogr 1993;17(3):438-41.

Aquinas SR, Tarey SD, Ravindran GD, Nagamani D, Ross C. Cryptococcal meningitis in AIDS--need for early diagnosis. J Assoc Physicians India 1996;44(3):178-80.

Awasthi M, Patankar T, Shah P, Castillo M. Cerebral cryptococcosis: atypical appearances on CT. Br J Radiol 2001;74(877):83-5.

Baker R, Haugen R. Tissue changes and tissue diagnosis in cryptococcosis, a study of 26 cases. Am J Clin Pathol 1955;25:4-24.

Bandettini R, Castagnola E, Calvillo M, et al. Voriconazole for cryptococcal meningitis in children with leukemia or receiving allogeneic hemopoietic stem cell transplant. J Chemother 2009;21:108-9.

Benham R. Cryptococcosis and blastomyocosis. Ann NY Acad Sci 1950;50:1299-1314.

Berger JR. The cerebellar seizures of Hughlings Jackson. Neurology 2000;54(1):272.

Berger JR, Moskowitz L, Fischl M, Kelley RE. Neurologic disease as the presenting manifestation of acquired immunodeficiency syndrome. South Med J 1987;80(6):683-6.

Berry AJ, Rinaldi MG, Graybill JR. Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS. Antimicrob Agents Chemother 1992;36(3):690-2.

Bouffard JP, Mena H, Ripple M, Troncoso J. Mesencephalic cryptococcal abscesses presenting with parkinsonism as an initial manifestation of AIDS. Mov Disord 2003;18(11):1354-7.

Bozzette SA, Larsen RA, Chiu J, et al. A placebo controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Eng J Med 1991;324:580-4.

Broom J, Woods M 2nd, Allworth A: Immune reconstitution inflammatory syndrome producing atypical presentations of cryptococcal meningitis: case report and a review of immune reconstitution-associated cryptococcal infections. Scand J Infect Dis 2006;38(3):219-221.

Buschke A. Ueber eine durch Coccidien Hervergerufene Krankheit des menschen. Deutsche Med Wochenschr 1895;21(3):14.

Busse O. Ueber parasitare zelleinschlusse und ihre zuchtung. Zentralbl Bakterial 1894;16:175-80.

Carbonara S, Regazzi M, Ciraci E, et al. Long-term efficacy and safety of TDM-assisted combination of voriconazole plus efavirenz in an AIDS patient with cryptococcosis and liver cirrhosis. Ann Pharmacother 2009;43:978-84.

Casadevall A, Spitzer ED, Webb D, Rinaldi MG. Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole. Antimicrob Agents Chemother 1993;37(6):1383-6.

Chang YC, Kwon-Chung KJ. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol 1994;14(7):4912-9.

Chang YC, Stins MF, McCaffery MJ, et al. Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun 2004;72:4985-95.

Chariyalertsak S, Supparatpinyo K, Sirisanthana T, Nelson KE. A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand. Clin Infect Dis 2002;34(2):277-84.

Chang LW, Phipps WT, Kennedy GE, Rutherford GW. Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV. Cochrane Datebase Syst Rev 2005;(3):CD004773.

Charlier C, Dromer F, Leveque C, et al. Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era. PLoS ONE 2008;3:e1950.

Chen CP, Wang KG. Cryptococcal meningitis in pregnancy. Am J Perinatol 1996;13(1):35-6.

Chen SH, Stins MF, Huang SH, et al. Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol 2003;52(Pt 11):961-70.

Cheng S. Factors affecting prognosis of cryptococcal meningitis. Zhonghua Shen Jing Jing Shen Ke Za Zhi 1992;25(4):240-2, 255.

Chotmongkol V, Siricharoensang S. Cryptococcal meningitis in pregnancy: a case report. J Med Assoc Thai 1991;74(9):421-2.

Chotmongkol V, Sookprasert A. Itraconazole in cryptococcal meningitis in pregnancy: a case report. J Med Assoc Thai 1992;75(10):606-8.

Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989;321(12):794-9.

Clark RA, Greer D, Atkinson W, Valainis GT, Hyslop N. Spectrum of Cryptococcus neoformans infection in 68 patients infected with human immunodeficiency virus. Rev Infect Dis 1990;12(5):768-77.

Cohen DB, Glasgow BJ. Bilateral optic nerve cryptococcosis in sudden blindness in patients with acquired immune deficiency syndrome. Ophthalmology 1993;100(11):1689-94.

Coker RJ, Murphy SM, Harris JR. Experience with liposomal amphotericin B (AmBisome) in cryptococcal meningitis in AIDS. J Antimicrob Chemother 1991;28(Suppl B):105-9.

Coker RJ, Viviani M, Gazzard BG, et al. Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS. AIDS 1993;7(6):829-35.

Curole DN. Cryptococcal meningitis in pregnancy. J Reprod Med 1981;26(6):317-9.

Currie BP, Casadevall A. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin Infect Dis 1994;19(6):1029-33.

Currie BP, Freundlich LF, Soto MA, Casadevall A. False-negative cerebrospinal fluid cryptococcal latex agglutination tests for patients with culture-positive cryptococcal meningitis. J Clin Microbiol 1993;31(9):2519-22.

Day JN, Chau TT, Wolbers M, et al. Combination antifungal therapy for cryptococcal meningitis. N Engl J Med 2013;368(14):1291-302.

de Gans J, Eeftinck Schattenkerk JK, van Ketel RJ. Itraconazole as maintenance treatment for cryptococcal meningitis in the acquired immune deficiency syndrome. Br Med J 1988;296:339.

de Gans J, Portegies P, Tiessens G, et al. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. AIDS 1992;6:185-90.

de Lalla F, Pellizzer G, Vaglia A, et al. Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short period. Clin Infect Dis 1995;20:263-6.

Delgrange E, Donckier JE. Cryptococcal meningitis and Cushing's syndrome. Lancet 2000;356(9226):343.

Denning DW, Armstrong RW, Lewis BH, Stevens DA. Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med 1991;91(3):267-72.

Dismukes W. Cryptococcosis. In: Wyngaarden J, Smith Jr L, Bennett J, editors. Cecil's textbook of medicine. Philadelphia: WB Saunders, 1992:1894-7.

Dupont B. Overview of the lipid formulations of amphotericin B. J Antimicrob Chemother 2002;49(Suppl A):31-6.

Eisenman HC, Casadevall A, McClelland EE. New insights on the pathogenesis of invasive Cryptococcus neoformans infection. Curr Infect Dis Rep 2007;9(6):457-64.

Ely EW, Peacock JE Jr, Haponik EF, Washburn RG. Cryptococcal pneumonia complicating pregnancy. Medicine (Baltimore) 1998;77(3):153-67.

Eng RH, Bishburg E, Smith SM, Kapila R. Cryptococcal infections in patients with acquired immune deficiency syndrome. Am J Med 1986;81(1):19-23.

Engstrom JW, Lowenstein DH, Bredesen DE. Cerebral infarctions and transient neurologic deficits associated with acquired immunodeficiency syndrome. Am J Med 1989;86(5):528-32.

Fay PM, Strominger MB. Wall-eyed bilateral internuclear ophthalmoplegia in central nervous system cryptococcosis. J Neuroophthalmol 1999;19(2):131-5.

Fraser DW, Ward JI, Ajello L, Plikaytis BD. Aspergillosis and other systemic mycoses. The growing problem. JAMA 1979;242(15):1631-5.

Friedman DI. Neuro-ophthalmic manifestations of human immunodeficiency virus infection. Neurol Clin 1991;9(1):55-72.

Fries BC, Lee SC, Kennan R, Zhao W, Casadevall A, Goldman DL. Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis. Infect Immun 2005;73:1779-87.

Garcia CA, Weisberg LA, Lacorte WS. Cryptococcal intracerebral mass lesions: CT-pathologic considerations. Neurology 1985;35(5):731-4.

Garrity JA, Herman DC, Imes R, Fries P, Hughes CF, Campbell RJ. Optic nerve sheath decompression for visual loss in patients with acquired immunodeficiency syndrome and cryptococcal meningitis with papilledema. Am J Ophthalmol 1993;116(4):472-8.

Giberson TP, Kalyan-Raman K. Cryptococcal meningitis: initial presentation of acquired immunodeficiency syndrome. Ann Emerg Med 1987;16(7):802-4.

Goel D, Kalita J, Misra UK. Basilar artery occlusion in cryptococcal meningitis. Neurol India 1999;47(3):245-6.

Golnik KC, Newman SA, Wispelway B. Cryptococcal optic neuropathy in the acquired immune deficiency syndrome. J Clin Neuroophthalmol 1991;11(2):96-103.

Graybill JR, Sobel J, Saag M, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 2000;30(1):47-54.

Gupta S, Ellis M, Cesario T, Ruhling M, Vayuvegula B. Disseminated cryptococcal infection in a patient with hypogammaglobulinemia and normal T cell functions. Am J Med 1987;82(1):129-31.

Hansemann DV. Uber eine bisher nicht beobachtete Gehirnerkrankung durch Hefen. Verh Dtsch Ges Pathol 1905;9:21-4.

Hay RJ, Mackenzie DW, Campbell CK, Philpot CM. Cryptococcosis in the United Kingdom and the Irish Republic: an analysis of 69 cases. J Infect 1980;2(1):13-22.

Ho TL, Lee HJ, Lee KW, Chen WL. Diffusion-weighted and conventional magnetic resonance imaging in cerebral cryptococcoma. Acta Radiol 2005;46(4):411-4.

Jabs DA, Green WR, Fox R, Polk BF, Bartlett JG. Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology 1989;96(7):1092-9.

Jarvis JN, Bicanic T, Loyse A, et al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis 2014;58(5):736-45.

Jarvis JN, Meintjes G, Rebe K, et al. Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial. AIDS 2012;26(9):1105-13.

Jenny-Avital ER, Abadi M. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin Infect Dis 2002;35(12):e128-33.

Jimenez-Lucho V, Ginsburg V, Krivan HC. Cryptococcus neoformans, Candida albicans, and other fungi bind specifically to the glycosphingolipid lactosylceramide (Gal beta 1-4Glc beta 1-1Cer), a possible adhesion receptor for yeasts. Infect Immun 1990;58(7):2085-90.

Johannessen DJ, Wilson LG. Mania with cryptococcal meningitis in two AIDS patients. J Clin Psychiatry 1988;49(5):200-1.

Jones JM, Craig WA. Cryptococcal meningitis: resolution eight months after antifungal therapy. South Med J 1983;76(12):1567-9.

Kalita J, Bansal R, Ayagiri A, Misra UK. Midbrain infarction: a rare presentation of cryptococcal meningitis. Clin Neurol Neurosurg 1999;101(1):23-5.

Kalra SP, Chadha DS, Singh AP, Sanchetee PC, Mohapatra AK. Cryptococcal meningitis in acquired immunodeficiency syndrome. J Assoc Physicians India 1999;47(10):958-61.

Kanaly CW, Selznick LA, Cummings TJ, Adamson DC. Cerebellar cryptococcoma in a patient with undiagnosed sarcoidosis: case report. Neurosurgery 2007;60:E571.

Keane JR. Neuro-ophthalmologic signs of AIDS: 50 patients. Neurology 1991;41(6):841-5.

Keane JR. Intermittent third nerve palsy with cryptococcal meningitis. J Clin Neuroophthalmol 1993;13(2):124-6.

Kida M, Abramowsky CR, Santoscoy C. Cryptococcosis of the placenta in a woman with acquired immunodeficiency syndrome. Hum Pathol 1989;20(9):920-1.

Kovacs JA, Kovacs AA, Polis M, et al. Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 1985;103(4):533-8.

Kuruvilla A. Cryptococcal meningitis and Cushing's syndrome. Lancet 2000;356(9226):342-3.

Kwon-Chung KJ, Rhodes JC. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect Immun 1986;51(1):218-23.

LaGatta MA, Jordan C, Khan W, Toomey J. Isolated pulmonary cryptococcosis in pregnancy. Obstet Gynecol 1998;92(4 Pt 2):682-4.

Lan SH, Chang WN, Lu CH, Lui CC, Chang HW. Cerebral infarction in chronic meningitis: a comparison of tuberculous meningitis and cryptococcal meningitis. QIM 2001;94(5):247-53.

Lang W, Miklossy J, Deruaz JP, et al. Definition and incidence of AIDS-associated CNS lesions. Prog AIDS Pathol 1990;2:89-101.

Larsen RA, Bozzette S, McCutchan JA, Chiu J, Leal MA, Richman DD. Persistent cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group. Ann Intern Med 1989;111:125-8.

Larsen RA, Leal MA, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. Ann Intern Med 1990;113:183-7.

Leake HA, Appleyard MN, Hartley JP. Successful treatment of resistant cryptococcal meningitis with amphotericin B lipid emulsion after nephrotoxicity with conventional intravenous amphotericin B. J Infect 1994;28(3):319-22.

Lee YC, Wang JT, Sun HY, Chen YC. Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection. J Microbiol Immunol Infect 2012;44(5):338-45.

Lipson BK, Freeman WR, Beniz J, et al. Optic neuropathy associated with cryptococcal arachnoiditis in AIDS patients. Am J Ophthalmol 1989;107(5):523-7.

Lu CH, Chang WN, Chang HW, Chuang YC. The prognostic factors of cryptococcal meningitis in HIV-negative patients. J Hosp Infect 1999;42(4):313-20.

Lui G, Lee N, Ip M, et al. Cryptococcosis in apparently immunocompetent patients. QJM 2006;99:143-51.

Manfredi R, Mazzoni A, Nanetti A, Mastroianni A, Coronado O, Chiodo F. Morphologic features and clinical significance of skin involvement in patients with AIDS-related cryptococcosis. Acta Derm Venereol 1996;76(1):72-4.

Maruki C, Nakano H, Shimoji T, Maeda M, Ishii S. Loss of vision due to cryptococcal optochiasmatic arachnoiditis and optocurative surgical exploration--case report. Neurol Med Chir (Tokyo) 1988;28(7):695-7.

Mathews VP, Alo PL, Glass JD, Kumar AJ, McArthur JC. AIDS-related CNS cryptococcosis: radiologic-pathologic correlation. AJNR Am J Neuroradiol 1992;13:1477-86.

Merkel GJ, Scofield BA. Conditions affecting the adherence of Cryptococcus neoformans to rat glial and lung cells in vitro. J Med Vet Mycol 1993;31(1):55-64.

Minamoto GY, Rosenberg AS. Fungal infections in patients with acquired immunodeficiency syndrome. Med Clin North Am 1997;81(2):381-409.

Murai H, Tokunaga H, Kubo I, et al. Myeloradiculitis caused by Cryptococcus neoformans infection in a patient with ulcerative colitis: a neuropathological study. J Neurol Sci 2006;247:236-8.

Nagappan V, Deresinski S. Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent. Clin Infect Dis 2007;45(12):1610-7.

Nierenberg NE, Thompson GR, Lewis JS, Hogan BK, Patterson TF. Voriconazole use and pharmacokinetics in combination with interferon-gamma for refractory cryptococcal meningitis in a patient receiving low-dose ritonavir. Med Mycol 2010;48(3):532-6.

Nightingale SD, Cal SX, Peterson DM, et al. Primary prophylaxis with fluconazole against systemic fungal infections in HIV-positive patients. AIDS 1992;6:191-4.

Nunnari G, Gussio M, Pinzone MR, et al. Cryptococcal meningitis in an HIV-1-infected person: relapses or IRIS? Case report and review of the literature. Eur Rev Med Pharmacol Sci 2013;17(11):1555-9.

Ofner S, Baker RS. Visual loss in cryptococcal meningitis. J Clin Neuroophthalmol 1987;7(1):45-8.

Okun E, Butler W. Ophthalmologic complications of cryptococcal meningitis. Arch Ophthalmol 1964;71:52-7.

Paugam A, Dupouy-Camet J, Blanche P, Gangneux JP, Tourte-Schaefer C, Sicard D. Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis. Clin Infect Dis 1994;19(5):975-6.

Peetermans W, Bobbaers H, Verhaegen J, Vandepitte J. Fluconazole-resistant Cryptococcus neoformans var gattii in an AIDS patient. Acta Clin Belg 1993;48(6):405-9.

Pereira CA, Fischman O, Colombo AL, Moron AF, Pignatari AC. Cryptococcal meningitis in pregnancy. Review of the literature. Report of 2 cases. Rev Inst Med Trop Sao Paulo 1993;35(4):367-71.

Perfect JR, Durack DT, Gallis HA. Cryptococcemia. Medicine (Baltimore) 1983;62(2):98-109.

Petrou P, Moscovici S, Leker RR, Itshayek E, Gomori JM, Cohen JE. Ventriculoperitoneal shunt for intracranial hypertension in cryptococcal meningitis without hydrocephalus. J Clin Neurosci 2012;19(8):1175-6.

Philpot CR, Lo D. Cryptococcal meningitis in pregnancy. Med J Aust 1972;2(18):1005-7.

Pinner RW, Hajjeh RA, Powderly WG. Prospects for preventing cryptococcosis in persons infected with human immunodeficiency virus. Clin Infect Dis 1995;21(Suppl 1):S103-7.

Pool A, Lowder L, Wu Y, Forrester K, Rumbaugh J. Neurovirulence of Cryptococcus neoformans determined by time course of capsule accumulation and total volume of capsule in the brain. J Neurovirol 2013;19(3):228-38.

Popovich MJ, Arthur RH, Helmer E. CT of intracranial cryptococcosis. AJNR Am J Neuroradiol 1990;11(1):139-42.

Porter KG, Sinnamon DG, Gillies RR. Cryptococcus neoformans-specific oligoclonal immunoglobulins in cerebrospinal fluid in cryptococcal meningitis. Lancet 1977;1(8024):1262.

Post MJ, Kursunoglu SJ, Hensley GT, Chan JC, Moskowitz LB, Hoffman TA. Cranial CT in acquired immunodeficiency syndrome: spectrum of diseases and optimal contrast enhancement technique. AJR Am J Roentgenol 1985;145(5):929-40.

Powderly WG, Saag MS, Cloud GA, et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med 1992;326(12):793-8.

Pyrgos V, Seitz AE, Steiner CA, Prevots DR, Williamson PR. Epidemiology of cryptococcal meningitis in the US: 1997-2009. PLoS One 2013;8(2):e56269.

Rippon J. Cryptococcosis. Medical mycology: The pathogenic fungi and the pathogenic actinomycetes. Philadelphia: WB Saunders, 1988:582-609.

Rolfes MA, Hullsiek KH, Rhein J, et al. The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis. Clin Infect Dis 2014. [Epub ahead of print]

Rosario M, Song SX, McCullough LD. An unusual case of stroke. Neurologist 2012;18:229-32.

Ross JJ, Katz JD. Cryptococcal meningitis and sarcoidosis. Scand J Infect Dis 2002;34(12):937-9.

Rozenbaum R, Goncalves AJ. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 1994;18(3):369-80.

Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med 1992;326(2):83-9.

Sacktor N, Lyles RH, Skolasky R, et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 2001;56(2):257-60.

Sadun F, De Negri AM, Santopadre P, Pivetti Pezzi P. Bilateral trochlear nerve palsy associated with cryptococcal meningitis in human immunodeficiency virus infection. J Neuroopthalmol 1999;19(2):118-9.

Saigal G, Post MJ, Lolayekar S, Murtaza A. Unusual presentation of central nervous system cryptococcal infection in an immunocompetent patient. AJNR Am J Neuroradiol 2005;26:2522-6.

Sancesario G, Palmieri G, Viola G, et al. Difficulty diagnosing chronic cryptococcal meningitis in idiopathic CD4+ lymphocytopenia. Neurol Sci 2011;32:19-24.

Saul RF, Gallagher JG, Mateer JE. Sudden hemiparesis as the presenting sign in cryptococcal meningoencephalitis. Stroke 1986;17(4):753-4.

Schimpff SC, Bennett JE. Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infection. J Allergy Clin Immunol 1975;55(6):430-41.

Seaton RA, Naraqi S, Wembri JP, Warrell DA. Predictors of outcome in Cryptococcus neoformans var. gattii meningitis. QJM 1996;89(6):423-8.

Selby RC, Lopes NM. Torulomas (cryptococcal granulomata) of the central nervous system. J Neurosurg 1973;38(1):40-6.

Shen CC, Cheng WY, Yang MY. Isolated intramedullary cryptococcal granuloma of the conus medullaris: case report and review of the literature. Scend J Infect Dis 2006;38:562-5.

Shih CC, Chen YC, Chang SC, Luh KT, Hsieh WC. Cryptococcal meningitis in non-HIV-infected patients. QJM 2000;93(4):245-51.

Silberfarb PM, Sarosi GA, Tosh FE. Cryptococcosis and pregnancy. Am J Obstet Gynecol 1972;112(5):714-20.

Sivasangeetha K, Harish BN, Sujatha S, Parija SC, Dutta TK. Cryptococcal meningoencephalitis diagnosed by blood culture. Indian J Med Microbiol 2007;25(3):282-4.

Skiest DJ, Hester LJ, Hardy RD. Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature. J Infect 2005;51:e289-97.

Snow RM, Dismukes E. Cryptococcal meningitis: diagnostic value of cryptococcal antigen in cerebrospinal fluid. Arch Intern Med 1975;135(9):1155-7.

Spitzer ED, Spitzer SG, Freundlich LF, Casadevall A. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 1993;341:595-6.

Stafford CR, Fisher JF, Fadel HE, Espinel-Ingroff AV, Shadomy S, Hamby M. Cryptococcal meningitis in pregnancy. Obstet Gynecol 1983;62(3 Suppl):35s-7s.

Steenbergen JN, Shuman HA, Casadevall A. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci U S A 2001;98(26):15245-50.

Stern JJ, Hartman BJ, Sharkey P, et al. Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. Am J Med 1988;85(4):477-80.

Stoddard J, Cutler E. Torula infection in man. Rockfeller Inst Med Res Monograph 1916;62:1-98.

Sugar AM, Saunders C. Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. Am J Med 1988;85(4):481-9.

Sungkanuparph S, Filler SG, Chetchotisakd P, et al. Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study. Clin Infect Dis 2009;49(6):931-4.

Taelman H, Clerinx J, Kagame A, Batungwanayo J, Nyirabareja A, Bogaerts J. Cryptococcosis, another growing burden for central Africa. Lancet 1991;338(8769):761.

Tan C. Intracranial hypertension causing visual failure in cryptococcus meningitis. Psychiatry 1988;51:944-6.

Tantisiriwat W, Powderly W. Cryptococcus. In: Schlossberg D, editor. Current therapy of infectious disease. St. Louis: Mosby, 2001:708-12.

Tien RD, Chu PK, Hesselink JR, Duberg A, Wiley C. Intracranial cryptococcosis in immunocompromised patients: CT and MR findings in 29 cases. AJNR Am J Neuroradiol 1991;12(2):283-9.

Tornero Estebanez C, Paricio Blasco A, Pons Espana E. A cerebral infarct associated with cryptococcal meningitis in an AIDS patient. An Med Interna 1992;9(4):206-7.

Valenzuela RM, Pula JH, Garwacki D, Cotter J, Kattah JC. Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab. J Neurol Sci 2014;340(1-2):109-11.

Vibhagool A, Sungkanuparph S Mootsikapun P, et al. Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study. Clin Infect Dis 2003;36(10):1329-31.

Vinters H, Anders K. Neuropathology of AIDS. Boca Raton: CRC Press, 1990.

Vuillemin P. Le Blastomycetes pathogenes. Rev Gen Sci 1901;12:32-51.

Wang W, Carm AR. Clinical manifestations of AIDS with cryptococcal meningitis. Chin Med J (Engl) 2001;114(8):841-3.

White M, Cirrincione C, Blevins A, Armstrong D. Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease. J Infect Dis 1992;165(5):960-3.

Wilbur L, Heyborne R. Transient loss of consciousness caused by cryptococcal meningitis in an immunocompetent patient: a case report. Cases J 2009:2:60.

Wu G, Vilchez RA, Eidelman B, Fung J, Kormos R, Kusne S. Cryptococcal meningitis, an analysis among 5,521 consecutive organ transplant recipients. Transpl Infect Dis 2002;4(4):183-8.

York J, Bodi I, Reeves I, Riordan-Eva P, Easterbrook PJ: Raised intracranial pressure complicating cryptococcal meningitis: immune reconstitution inflammatory syndrome or recurrent cryptococcal disease? J Infect Dis 2005;51(2):165-71.

Yu YL, Lau YN, Woo E, Wong KL, Tse B. Cryptococcal infection of the nervous system. Q J Med 1988;66(249):87-96.

Yu YL, Woo E, Chan FL, Chan TY, Chan GC. Cerebral infarction in cryptococcal meningitis. Clin Exp Neurol 1989;26:193-7.

Zhou Q, Gault RA, Kozel TR, Murphy WJ: Protection from direct cerebral Cryptococcus infection by interferon-gamma-dependent activation of microglial cells. J Immunol 2007;178(9):5753-61.

Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med 1986;104(2):234-40.

**References especially recommended by the author or editor for general reading.

In This Article

Historical note and nomenclature
Clinical manifestations
Clinical vignette
Pathogenesis and pathophysiology
Differential diagnosis
Diagnostic workup
Prognosis and complications
References cited